InvestorsHub Logo
Followers 12
Posts 1261
Boards Moderated 0
Alias Born 04/12/2011

Re: A deleted message

Thursday, 10/13/2016 2:52:04 PM

Thursday, October 13, 2016 2:52:04 PM

Post# of 465113
As a standard of proof in medical trials, 7 people is minuscule!
It's enough to draw some attention and justify a larger, tighter trial.
Get real. Read the literature and check out other past ALZ clinical trials.
I also have money in several small bios trying to find a cure for cancer ( i'm a survivor) and i see how clinical trials are conducted and evaluated..Same death sentence problem. Check out clinicaltrials.gov
I take it you are pretty new to this stock, but i've been in it quite a while and have an overview you lack.
"Minimal capital"? Do your DD and under financials you'll see that we spend twice as much on admin than we do on R&D. That's part of why the trials are lagging and why serious bio investors are reluctant to bid up the PPS.
Me. a troll? Giggle...A curmudgeon for sure, but not a troll.
The Biogen deal is a good thing, but so small, exploratory, and pre-clinical as to count for little, at least for now. At best we are many years away from an approved MS drug.
The MJF deal is a bit more advanced and i'm pleased to have them shoulder the burden on that...But that's way, way off in the future too.
The good doctor is much better than his predecessor, but he's helped himself to a very big piece of our pie and is compensating himself awfully well for a tiny, early stage, cash flow negative company.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News